Vaccine maker Moderna, Inc. (MRNA) announced that it has procured a supply order for an additional 50 million doses of its COVID-19 vaccine and its updated variant booster, if approved, for delivery in 2022. Shares were down 1.3% in pre-market trading at the time of writing. The company will join the S&P 500 today. Shares have been volatile since the news broke, gaining 23.8% in the past five days. (See Moderna stock charts on TipRanks) The company said it has partnered with the Ministry of Health, Labour, and Welfare of Japan (MHLW) and Takeda Pharmaceutical Company, Ltd. (TAK) for the new order.
https://www.tipranks.com/news/moderna-partners-with-takeda-and-govt-of-japan-for-50m-vaccine-doses?utm_source=advfn.com&utm_medium=referral
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Aug 2021 to Sep 2021 Click Here for more Moderna Charts.
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Sep 2020 to Sep 2021 Click Here for more Moderna Charts.